Inhibition of cyclin-dependent kinases improves CA1 neuronal survival and behavioral performance after global ischemia in the rat - PubMed (original) (raw)

Inhibition of cyclin-dependent kinases improves CA1 neuronal survival and behavioral performance after global ischemia in the rat

Fuhu Wang et al. J Cereb Blood Flow Metab. 2002 Feb.

Abstract

Increasing evidence suggests that cyclin-dependent kinases participate in neuronal death induced by multiple stresses in vitro. However, their role in cell death paradigms in vivo is not well characterized. Accordingly, the authors examined whether cyclin-dependent kinase inhibition resulted in functionally relevant and sustained neuroprotection in a model of global ischemia. Intracerebroventricular administration of the cyclin-dependent kinase inhibitor flavopiridol, immediately or at 4 hours postreperfusion after a global insult, reduced injury in the CA1 of the hippocampus when examined 7 days after reperfusion. No significant protection was observed when flavopiridol was administered 8 hours after reperfusion. The tumor-suppressor retinoblastoma protein, a substrate of cyclin-dependent kinase, was phosphorylated on a cyclin-dependent kinase consensus site after the global insult; this phosphorylation was inhibited by flavopiridol administration. Importantly, flavopiridol had no effect on core body temperature, suggesting that the mechanism of neuroprotection was through cyclin-dependent kinase inhibition but not through hypothermia. Furthermore, inhibition of cyclin-dependent kinases improved spatial learning behavior as assessed by the Morris water maze 7 to 9 days after reperfusion. However, the histologic protection observed at day 7 was absent 28 days after reperfusion. These results indicate that cyclin-dependent kinase inhibition provides an extended period of morphologic and functional neuroprotection that may allow time for other neuroprotective modalities to be introduced.

PubMed Disclaimer

Cited by

Role of cell cycle re-entry in neurons: a common apoptotic mechanism of neuronal cell death.
Folch J, Junyent F, Verdaguer E, Auladell C, Pizarro JG, Beas-Zarate C, Pallàs M, Camins A. Folch J, et al. Neurotox Res. 2012 Oct;22(3):195-207. doi: 10.1007/s12640-011-9277-4. Epub 2011 Oct 1. Neurotox Res. 2012. PMID: 21965004 Review.
Cell division in the CNS: protective response or lethal event in post-mitotic neurons?
Yang Y, Herrup K. Yang Y, et al. Biochim Biophys Acta. 2007 Apr;1772(4):457-66. doi: 10.1016/j.bbadis.2006.10.002. Epub 2006 Oct 7. Biochim Biophys Acta. 2007. PMID: 17158035 Free PMC article. Review.
Delayed treatment with systemic (S)-roscovitine provides neuroprotection and inhibits in vivo CDK5 activity increase in animal stroke models.
Menn B, Bach S, Blevins TL, Campbell M, Meijer L, Timsit S. Menn B, et al. PLoS One. 2010 Aug 12;5(8):e12117. doi: 10.1371/journal.pone.0012117. PLoS One. 2010. PMID: 20711428 Free PMC article.
Cell cycle activation and CNS injury.
Stoica BA, Byrnes KR, Faden AI. Stoica BA, et al. Neurotox Res. 2009 Oct;16(3):221-37. doi: 10.1007/s12640-009-9050-0. Epub 2009 Apr 21. Neurotox Res. 2009. PMID: 19526282
Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease.
Smith PD, Crocker SJ, Jackson-Lewis V, Jordan-Sciutto KL, Hayley S, Mount MP, O'Hare MJ, Callaghan S, Slack RS, Przedborski S, Anisman H, Park DS. Smith PD, et al. Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13650-5. doi: 10.1073/pnas.2232515100. Epub 2003 Oct 31. Proc Natl Acad Sci U S A. 2003. PMID: 14595022 Free PMC article.

Inhibition of cyclin-dependent kinases improves CA1 neuronal survival and behavioral performance after global ischemia in the rat - PubMed (original) (raw)